Blockade of CD40-CD154 interferes with human T cell engraftment in scid mice

Cell Transplantation

Volumn 7, Issue 1, 1998, Pages 25-35

  Foy, Teresa M ^a,e   Mcilraith, Melissa ^b   Masters, Sally R ^a   Dunn, Jonathan J ^a   Rossini, Aldo A ^c   Shultz, Leonard D ^d   Hesselton, Ruth Ann M ^c   Wagar, Eric J ^c   Lipsky, Peter E ^b   Noelle, Randolph J ^a   Greiner, Dale L ^c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d JACKSON LABORATORY   (United States)

^e GLAXOSMITHKLINE   (United States)

Author keywords

B cell; CD154; CD40; hu PBL scid mice; T cell

Indexed keywords

CD40 ANTIGEN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; B-LYMPHOCYTES; CD40 LIGAND; CELL DIFFERENTIATION; CELL TRANSPLANTATION; GRAFT SURVIVAL; HUMANS; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, SCID; T-LYMPHOCYTES; TETANUS TOXOID; TRANSPLANTATION, HETEROLOGOUS;

EID: 13144267789     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0963-6897(97)00113-9     Document Type: Article

References (32)

1. Banchereau, J.; Bazan, F.; Blanchard, D.; Briere, F.; Galizzi, J.P.; van Kooten, C.; Liu, Y.J.; Rousset, F.; Saeland, S. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922; 1994.
2. Buhlmann, J.E.; Foy, T.M.; Aruffo, A.; Crassi, K.M.; Ledbetter, J.A.; Green, W.R.; Xu, J.C.; Shultz, L.D.; Roopesian, D.; Flavell, R.A.; Fast, L.; Noelle, R.J.; Durie, F.H. In the absence of a CD40 Signal, B Cells Are Tolerogenic. Immunity 2:645-653; 1995.
3. Carlsson, R.; Martensson, C.; Kalliomaki, S.; Ohlin, M.; Borrebaeck, C.A. Human peripheral blood lymphocytes transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral response. J. Immunol. 148:1065-1073; 1992.
4. Castigli, E.; Alt, F.W.; Davidson, L.; Bottaro, A.; Mizoguchi, E.; Bhan, A.K.; Geha, R.S. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA 91:12135-12139; 1994.
5. Chen, F.A.; Williams, S.S.; Fanslow, W.C.; Bankert, R.B. Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand. J. Immunol. 155:2833-2840; 1995.
6. de Boer, M.; Kasran, A.; Kwekkeboom, J.; Walter, H.; Vandenberghe, P.; Ceuppens, J.L. Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells. Eur. J. Immunol. 23:3120-3125; 1993.
7. Duchosal, M.A.; Eming, S.A.; McConahey, P.J.; Dixon, F.J. The hu-PBL-SCID mouse model: Long term human serologic evolution associated with the xenogeneic transfer of human peripheral blood leukocytes into SCID mice. Cell. Immunol. 139:468-477; 1992.
8. Durie, F.H.; Aruffo, A.; Ledbetter, J.A.; Crassi, K.M.; Green, W.R.; Noelle, R.J. Antibody to the ligand of CD40, gp39, blocks the occurence of the acute and chronic forms of graft-versus-host disease. J. Clin. Invest. 94:1333-1338; 1994.
9. Durie, F.H.; Fava, R.A.; Foy, T.M.; Aruffo, A.; Ledbetter, J.A.; Noelle, R.J. Prevention of collagen- Induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328-1330; 1993.
10. Foy, T.; Aruffo, A.; Bajorath, J.; Buhlmann, J.E.; Noelle, R.J. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14:591-617; 1996.
11. Foy, T.M.; Aruffo, A.; Ledbetter, J.A.; Noelle, R.J. In vivo CD40-gp39 interactions are essential for thymus-dependent immunity. II. Prolonged in vivo suppression of primary and secondary humoral immune responses by an antibody targeted to the CD40 ligand, gp39. J. Exp. Med. 178:1567-1575; 1993.
12. Foy, T.M.; Laman, J.D.; Ledbetter, J.A.; Aruffo, A.; Claassen, E.; Noelle, R.J. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157-164; 1994.
13. Grewal, I.S.; Xu, J.; Flavell, R.A. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378:617-620; 1995.
14. Heeg, K.; Wagner, H. Induction of peripheral tolerance to class I major histocompatibility complex (MHC) alloantigens in adult mice: Transfused class I MHC-incompatible splenocytes veto clonal responses of antigen-reactive Lyt-2+ T cells. J. Exp. Med. 172:719-728; 1990.
15. Hesselton, R.M.; Greiner, D.L.; Mordes, J.P.; Rajan, T.V.; Sullivan, J.L.; Shultz, L.D. High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice. J. Infect. Dis. 172: 974-782; 1995.
16. Hollenbaugh, D.; Grosmaire, L.; Kullas, C.D.; Chalupny, N.J.; Noelle, R.J.; Stamenkovic, I.; Ledbetter, J.A.; Aruffo, A. The human T cell antigen gp39, a member of the TNF gene family, is aligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 11:4313-4321; 1992.
17. Hollenbaugh, D.; Ochs, H.D.; Noelle, R.J.; Ledbetter, J.A.; Aruffo, A. The role of CD40 and its ligand in the regulation of the immune response. Immunol. Rev. 138: 23-37; 1994.
18. Kawabe, T.; Naka, T.; Yoshida, K.; Tanaka, T.; Fujiwara, H.; Suematsu, S.; Yoshida, N.; Kishimoto, T.; Kikutani, H. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167-178; 1994.
19. Kennedy, M.K.; Mohler, K.M.; Shanebeck, K.D.; Baum, P.R.; Picha, K.S.; Ottene-Evans, C.A.; Janeway, C.A.; Grabstein, K.H. Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur. J. Immunol. 24:116-123; 1994.
20. Kreiger, J.I.; Grammer, S.F.; Grey, H.M.; Chestnut, R.W. Antigen presentation by splenic B cells: Resting B cells are ineffective, whereas activated B cells are effective accessory cell for T cell responses. J. Immunol. 135:2937-2946; 1995.
21. Kuiper, H.M.; Brouwer, B.M.; de Boer, M.; Parren, P., van Lier, R.A. Differences in responsiveness to CD3 stimulation between naive and memory CD4+ T cells cannot be overcome by CD28 costimulation. Eur. J. Immunol. 24: 1956-1960; 1994.
22. Larsen, C.P.; Elwood, E.T.; Alexander, D.Z.; Ritchie, S.C.; Hendrix, R.; Tucker, B.C.; Cho, H.R.; Aruffo, A.; Hollenbaugh, D.; Linsley, P.S.; Winn, K.J.; Pearson, T.C. Longterm acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434-438; 1996.
23. McCune, J.M.; Namikawa, R.; Kaneshima, H.; Schultz, L.D.; Weissman, I.L. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632-1635; 1988.
24. Mishell, B.; Skiigi, S.M.; Henry, C.; Chan, E.L.; North, J.; Gallily, R.; Slomich, M.; Miller, K.; Marbrook, J.; Parks, D.; Good, A.H. Preparation of mouse cell suspensions. In: Shiigi, B.M.; Shiigi, S.M.; eds. Selected methods in cellular immunology. San Francisco: W.H. Freeman and Co.; 1980.
25. Mosier, D.E.; Gulizia, R.J.; Baird, S.M.; Wilson, D.B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335: 256-259; 1988.
26. Nishioka, Y.; Lipsky, P.E. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration. J. Immunol. 153:1027-1036; 1994.
27. Noelle, R.J.; Roy, M.; Shepherd, D.M.; Stamenkovic, I.; Ledbetter, J.A.; Aruffo, A. A novel ligand on activated T helper cells binds CD40 and transduces the signal for the cognate activation of B cells. Proc. Natl. Acad. Sci. USA 89:6550-6554; 1997.
28. Parker, D.C.; Greiner, D.L.; Phillips, N.E.; Appel, M.C.; Steele, A.W.; Durie, F.H.; Noelle, R.J.; Mordes, J.P.; Rossini, A.A. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. Sci. USA 92:9560-9564; 1995.
29. Ranheim, E.A.; Kipps, T.J. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925-935; 1993.
30. + T Cell Repertoire in hu-PBL-SCID Chimeras. J. Exp. Med. 180:1817-1827; 1994.
31. Tohma, S.; Lipsky, P.E. Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. Induction of human B cell responses by fixed activated T cells. J. Immunol. 146:2544-2552; 1991.
32. Xu, J.; Foy, T.M.; Laman, J.D.; Dunn, J.J.; Waldschmidt, T.J.; Elsemore, J.; Noelle, R.J.; Flavell, R.A. Mice deficient for the CD40 ligand. Immunity 1:423-431; 1994.